NCT06046651

Brief Summary

To collect lab data from capillary and venous blood specimens for use in analytical research studies to support the development and validation of laboratory procedures.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
89mo left

Started Aug 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Aug 2023Aug 2033

Study Start

First participant enrolled

August 16, 2023

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

September 6, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2033

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2033

Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

10 years

First QC Date

September 6, 2023

Last Update Submit

November 13, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Correlation between capillary and venous samples upon collection

    R-value comparing the lab readings generated by venous and capillary samples for a specific blood analyte immediately upon collection

    10 years

  • Stability of the capillary blood sample after storage on Days 1, 2, and 3

    Median error % to compare the difference in values of each capillary sample after storage for a certain period of time (e.g., Days 1, 2, and 3) for a specific analyte when compared to the lab reading generated by the venous sample immediately upon collection

    10 years

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy members of the community aged 18 years and over

You may qualify if:

  • Any gender, in good general health
  • Must be 18 years old or older, inclusive at enrollment
  • Must be willing to provide capillary blood samples via a fingerstick and venous blood samples, including self-collection and collection by a licensed healthcare professional
  • Must be able to read, understand, and willingly sign an Informed Consent Form (ICF) and complete a brief health questionnaire
  • Must be able to read, speak and understand English
  • Must be available to attend one study visit at Investigator's laboratory or a third-party laboratory designated by the Investigator or collect samples at home, at the discretion of the Investigator.

You may not qualify if:

  • Individuals who are unable to provide a blood sample due to any illness
  • Individuals participating in another research study, that the Investigator feels may compromise study outcomes
  • Individuals having an acute or chronic disease or medical condition, including pregnancy, which could excessively increase study risk in the opinion of the Investigator or compromise study outcomes
  • Individuals who are unlikely to be available for the duration of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roman Health Ventures Study Site

San Francisco, California, 94107, United States

RECRUITING

MeSH Terms

Conditions

Metabolic DiseasesSexual Dysfunction, PhysiologicalAlopecia

Condition Hierarchy (Ancestors)

Nutritional and Metabolic DiseasesGenital DiseasesUrogenital DiseasesHypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Nitin Vaswani, MD

    Principal Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nitin Vaswani, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2023

First Posted

September 21, 2023

Study Start

August 16, 2023

Primary Completion (Estimated)

July 31, 2033

Study Completion (Estimated)

August 15, 2033

Last Updated

November 14, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

No IPD will be shared with other researchers

Locations